SonoCiné

medical devices

About

The SonoCiné Automated Whole-Breast Ultrasound System (AWBUS) was designed specifically for Whole-Breast Ultrasound examinations adjunctive to screening mammography for women with dense breast tissue. Market Clearance and Approvals --SonoCiné AWBUS has been cleared by the FDA as an adjunct to mammography (but not a replacement for screening mammography). --SonoCiné AWBUS has been approved by Health Canada for breast cancer screening, 2011. --SonoCiné AWBUS has been approved for breast cancer screening in 27 countries of the European Union, 2012. --The SonoCiné technology and its application are protected by 7 U.S. and 14 international patents. --There are 3 U.S. and 5 foreign patents pending. SonoCiné AWBUS is an accessory to your own state-of-the-art ultrasound system. --Does not require a dedicated room. --Uses the transducer(s) of your existing ultrasound system. --When SonoCiné is not in use your room and system are free for other uses. SonoCiné AWBUS has been clinically tested and reported in a peer-reviewed published screening study (large, prospective, blinded, multicenter trial). --European Radiology, March, 2010

Technologies

Outlook WordPress.org Mobile Friendly Gravity Forms Google Font API Apache reCAPTCHA Google Analytics

Keywords

breast ultrasound dense breast tissue automated whole breast ultrasound health care telehealth oncology radiology patient comfort diagnostic ultrasound breast imaging technology early cancer detection diagnostic accuracy health tech clinical validation early detection breast exam recording revenue opportunities telemedicine medical device mammogram supplement video exam recording breast cancer missed on mammogram telehealth breast screening medical equipment b2b awbus breast health reimbursement for ultrasound dense breast cancer detection breast cancer early diagnosis

Location

8850 Terabyte Court, Reno, Nevada, United States, 89521

Related Companies

Companies in the same industry